Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Models for Drug Testing: Organoids & Tissue Chips 2022

Abstract



The Next Evolution in Microfluidic 3D Printing

Hemdeep Patel, President and CEO, CADworks3D

Over the last decade, 3D printing has changed the way designs are created, evaluated and iterated in all industries and in every facet of life. Since 2016, CADworks3D has been an active player in the world of microfluidics & bio-engineering by showcasing how 3D printers can radically improve the cycle of design, evaluation and iteration.  The CADworks3D line of microfluidic 3D printers and 3D materials has users to test a wide range of devices from clear microfluidic encapsulated chips to master molds used for casting PDMS devices. Our newest open source ProFluidics 285D microfluidic 3D printer equipped with updated optics, a next generation projector and advanced software will allow users to reproduce features that are more true to the design.  Furthermore, the tell sign of pixel burn and shadow that was characteristic of the previous generation 3D printers are now a thing of the past allowing users to create smoother, superior quality surfaces finish.  The ProFluidics 285D will allow users to create high quality clear microfluidic devices and master molds for casting PDMS devices.


Add to Calendar ▼2022-09-13 00:00:002022-09-14 00:00:00Europe/London3D-Models for Drug Testing: Organoids and Tissue Chips 20223D-Models for Drug Testing: Organoids and Tissue Chips 2022 in SeattleSeattleSELECTBIOenquiries@selectbiosciences.com